January 6, 2021
PAR-18-580 - Investigational New Drug (IND)-enabling Development of Medications to Treat Alcohol Use disorder and Alcohol-related disorders (UT2 Clinical Trial Optional)
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
The purpose of this Notice is to extend the expiration date for PAR-18-580 "Investigational New Drug (IND)-enabling Development of Medications to Treat Alcohol Use disorder and Alcohol-related disorders (UT2 Clinical Trial Optional)" by one receipt cycle. PAR-18-580 will now expire on March 26, 2021.
Due to the extension, the following dates will be added:
The following sections of the FOA have been changed:
Part 1. Overview Information, Key Dates
Currently reads:
Application Due Date(s): March 27, 2018; December 4, 2018; March 27, 2019; December 4, 2019; March 27, 2020; December 4, 2020, by 5:00 PM local time of applicant organization.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Scientific Merit Review: July 2018, March 2019, July 2019, March 2020, July 2020, March 2021
Advisory Council Review: August 2018, May 2019, August 2019, May 2020, August 2020, May 2021
Expiration Date: December 5, 2020
Revised to read (changes shown in italics):
Application Due Date(s): March 27, 2018; December 4, 2018; March 27, 2019; December 4, 2019; March 27, 2020; December 4, 2020; March 25, 2021, by 5:00 PM local time of applicant organization.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Scientific Merit Review: July 2018, March 2019, July 2019, March 2020, July 2020, March 2021, July 2021
Advisory Council Review: August 2018, May 2019, August 2019, May 2020, August 2020, May 2021, October 2021
Expiration Date: March 26, 2021
All other aspects of this FOA remain unchanged.
Raye Z. Litten, Ph.D.
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Telephone: 301-443-0636
Email: rlitten@mail.nih.gov